Requires insurers to develop plans for coverage and access to nonnarcotic, nonopioid and nonmedication pain management for moderate to severe pain. It further restricts utilization review for nonopioid drugs.

Plain-English Summary

This bill would require health insurance companies in Rhode Island to create specific plans ensuring their customers have access to pain management options that don't involve opioids or narcotics. This includes both non-opioid medications and completely non-drug approaches to treating moderate to severe pain, such as physical therapy, chiropractic care, or other alternative treatments. Essentially, insurers would need to show they have a clear strategy for making these alternatives available and affordable to their policyholders.

The bill also places new limits on a process called "utilization review," which is when insurance companies evaluate whether a treatment is medically necessary before agreeing to cover it. Specifically, it would restrict how insurers can use this review process when a doctor prescribes a non-opioid drug for pain management. This means it would be harder for insurance companies to delay or deny coverage for non-opioid pain treatments that a doctor has already recommended.

This legislation would primarily affect Rhode Island residents who have private health insurance and are dealing with moderate to severe pain conditions. It would also directly impact insurance companies operating in the state, requiring them to update their coverage policies and internal review processes. Doctors and other healthcare providers could also be affected, as it may make it easier for their non-opioid treatment recommendations to be covered without additional insurance hurdles. The bill has been referred to the Senate Health and Human Services Committee for further review.